Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Metabolic Syndrome and Related Disorders
ISSN 1540-4196 · eISSN 1557-8518 · Mary Ann Liebert Inc. · United States · Quarterly · Founded 2003
Metabolic Syndrome and Related Disorders: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.59; subscription journal; review 6–12 weeks (community reports); community-reported acceptance: fairly easy; 47 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Metabolic Syndrome and Related Disorders is published by Mary Ann Liebert Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Adipokines, Inflammation, and Metabolic Diseases and Liver Disease Diagnosis and Treatment, together about 40.3% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism and Physiology. (generated from OpenAlex topic counts and CAS ranking data)
Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma. Metabolic Syndrome and Related Disorders coverage includes: -Insulin resistance- Central obesity- Glucose intolerance- Dyslipidemia with elevated triglycerides- Low HDL-cholesterol- Microalbuminuria- Predominance of small dense LDL-cholesterol particles- Hypertension- Endothelial dysfunction- Oxidative stress- Inflammation- Related disorders of polycystic ovarian syndrome, fatty liver disease (NASH), and gout
Source: LetPub
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine21.2%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine12.2%
- Liver Disease Diagnosis and TreatmentMedicine6.9%
- Obesity, Physical Activity, DietMedicine5.6%
- Diet, Metabolism, and DiseaseMedicine4.8%
- Cardiovascular Disease and AdiposityMedicine4.7%
- Diet and metabolism studiesMedicine4.6%
- Nutrition and Health in AgingMedicine3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.59LetPub ·
- Impact factor (publisher)
- 1.6Publisher website ·
- 5-year impact factor (publisher)
- 1.9Publisher website ·
- CiteScore 2026-06
- 3.5LetPub ·
- SJR 2026-06
- 0.55LetPub ·
- SNIP 2026-06
- 0.54LetPub ·
- h-index
- 40LetPub ·
- h-index
- 74OpenAlex ·
- i10-index
- 768OpenAlex ·
- 2-year mean citedness
- 1.77OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 3.47%LetPub ·
Volume
- Articles per year
- 45LetPub ·
Articles by year OpenAlex count · 1,598 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 45 | 2 | 15 |
| 2025 | 47 | 6 | 68 |
| 2024 | 88 | 14 | 235 |
| 2023 | 76 | 9 | 433 |
| 2022 | 73 | 6 | 539 |
| 2021 | 67 | 8 | 620 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Mary Ann Liebert Inc.
- Country or region
- United States
- Language
- English
- Frequency
- Quarterly
- Founded
- 2003
- ISSN
- 1540-4196
- Electronic ISSN
- 1557-8518
- Latest issue on the website
- Volume 24, Issue 7 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Metabolic Syndrome and Related Disorders
What CAS zone is Metabolic Syndrome and Related Disorders in?
In the 2025 upgraded edition of the CAS Journal Ranking, Metabolic Syndrome and Related Disorders is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Metabolic Syndrome and Related Disorders?
The latest impact factor listed by LetPub is 1.59; CiteScore 3.5, h-index 74.
How long does peer review take at Metabolic Syndrome and Related Disorders?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Metabolic Syndrome and Related Disorders?
According to LetPub and DOAJ records, Metabolic Syndrome and Related Disorders is indexed in SCIE and Scopus.
Is Metabolic Syndrome and Related Disorders open access, and what is the APC?
Metabolic Syndrome and Related Disorders is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .